Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christopher Lieu

Concepts (411)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
53
2026
837
9.900
 Why?
Antineoplastic Combined Chemotherapy Protocols
25
2026
1842
2.840
 Why?
Colonic Neoplasms
9
2026
261
2.700
 Why?
Biomarkers, Tumor
23
2026
1300
2.430
 Why?
Molecular Targeted Therapy
9
2019
441
1.870
 Why?
Antineoplastic Agents
14
2021
2209
1.820
 Why?
Antibodies, Monoclonal, Humanized
12
2026
935
1.730
 Why?
Rectal Neoplasms
7
2023
153
1.620
 Why?
Bevacizumab
5
2024
142
1.580
 Why?
Immunotherapy
5
2026
663
1.520
 Why?
Benzimidazoles
3
2024
192
1.480
 Why?
Neoplasms
14
2025
2823
1.420
 Why?
Microsatellite Instability
11
2026
52
1.130
 Why?
Drug Resistance, Neoplasm
10
2026
880
1.130
 Why?
Pancreatic Neoplasms
11
2025
933
1.060
 Why?
Mutation
15
2025
4080
1.030
 Why?
Circulating Tumor DNA
5
2026
41
1.020
 Why?
Neoplasm Staging
14
2026
1422
1.000
 Why?
Age of Onset
9
2024
559
0.970
 Why?
Gastrointestinal Neoplasms
2
2025
76
0.940
 Why?
Tankyrases
1
2025
13
0.930
 Why?
Cetuximab
5
2025
108
0.840
 Why?
Neuroendocrine Tumors
6
2024
111
0.840
 Why?
Vascular Endothelial Growth Factor A
4
2020
562
0.830
 Why?
Fluorouracil
8
2026
210
0.790
 Why?
Proto-Oncogene Proteins p21(ras)
4
2019
261
0.780
 Why?
Humans
108
2026
144748
0.770
 Why?
Oncologists
1
2023
46
0.770
 Why?
Proto-Oncogene Proteins B-raf
6
2024
230
0.740
 Why?
Indoles
1
2025
487
0.700
 Why?
Antibodies, Monoclonal
6
2023
1478
0.690
 Why?
Leucovorin
7
2026
87
0.660
 Why?
Middle Aged
45
2026
35640
0.650
 Why?
Pyrimidinones
2
2024
127
0.640
 Why?
Wnt Signaling Pathway
3
2025
213
0.640
 Why?
Carcinoma, Pancreatic Ductal
4
2025
308
0.630
 Why?
Aged
36
2026
25564
0.620
 Why?
Colectomy
2
2026
107
0.620
 Why?
DNA Mismatch Repair
5
2026
50
0.610
 Why?
Camptothecin
5
2025
125
0.600
 Why?
Pyridones
2
2024
198
0.600
 Why?
Early Detection of Cancer
4
2025
449
0.590
 Why?
Neoplasm Metastasis
9
2025
689
0.580
 Why?
Disease-Free Survival
8
2026
725
0.570
 Why?
Piperidines
2
2017
221
0.560
 Why?
Adult
40
2026
40359
0.550
 Why?
Neoadjuvant Therapy
6
2026
442
0.540
 Why?
Cyclosporine
1
2018
266
0.520
 Why?
Azetidines
1
2017
47
0.520
 Why?
Genetic Predisposition to Disease
4
2022
2444
0.510
 Why?
Appendiceal Neoplasms
2
2020
28
0.500
 Why?
Terminology as Topic
1
2019
253
0.500
 Why?
Chemotherapy, Adjuvant
6
2026
395
0.490
 Why?
Male
47
2026
72211
0.480
 Why?
Precision Medicine
2
2026
447
0.470
 Why?
Neoplasms, Unknown Primary
2
2026
20
0.460
 Why?
Female
48
2026
78074
0.460
 Why?
MAP Kinase Kinase Kinases
1
2015
71
0.450
 Why?
Adrenal Gland Neoplasms
3
2022
90
0.450
 Why?
Patient Rights
1
2015
11
0.450
 Why?
Medical Oncology
5
2023
328
0.450
 Why?
Treatment Outcome
16
2026
11498
0.450
 Why?
Kaplan-Meier Estimate
7
2025
924
0.450
 Why?
Therapies, Investigational
1
2015
18
0.440
 Why?
Drug and Narcotic Control
1
2015
26
0.440
 Why?
Drugs, Investigational
1
2015
31
0.440
 Why?
Neovascularization, Pathologic
2
2013
295
0.430
 Why?
Healthcare Disparities
1
2021
700
0.420
 Why?
Relaxation Therapy
1
2014
19
0.410
 Why?
Leisure Activities
1
2014
30
0.410
 Why?
Stroke Rehabilitation
1
2014
43
0.400
 Why?
Adenocarcinoma
5
2023
926
0.400
 Why?
Pyrazines
2
2018
88
0.400
 Why?
Microsatellite Repeats
2
2024
161
0.380
 Why?
Drug Evaluation, Preclinical
1
2013
199
0.380
 Why?
Clinical Trials as Topic
4
2025
1048
0.380
 Why?
Immunoglobulin G
1
2017
900
0.380
 Why?
Drug Design
1
2013
174
0.370
 Why?
ErbB Receptors
5
2017
617
0.370
 Why?
Carcinoma, Signet Ring Cell
1
2011
17
0.340
 Why?
Xenograft Model Antitumor Assays
7
2025
949
0.340
 Why?
Cell Transformation, Neoplastic
1
2013
341
0.340
 Why?
Terminal Care
1
2015
256
0.340
 Why?
Carcinoma, Squamous Cell
2
2026
649
0.320
 Why?
Imidazoles
2
2024
252
0.320
 Why?
Fibroblast Growth Factors
1
2011
189
0.320
 Why?
Organoplatinum Compounds
3
2026
51
0.320
 Why?
Dose-Response Relationship, Drug
3
2025
2061
0.310
 Why?
src-Family Kinases
1
2010
96
0.300
 Why?
Clinical Decision-Making
4
2024
349
0.300
 Why?
Genomics
4
2025
829
0.290
 Why?
Maximum Tolerated Dose
2
2025
206
0.290
 Why?
Patient Selection
3
2019
699
0.290
 Why?
Boronic Acids
1
2008
34
0.280
 Why?
Aged, 80 and over
14
2026
8103
0.280
 Why?
Disease Management
4
2021
647
0.280
 Why?
Janus Kinase 2
1
2008
32
0.280
 Why?
Stomach Neoplasms
3
2022
120
0.270
 Why?
Myeloproliferative Disorders
1
2008
27
0.270
 Why?
Carboplatin
1
2008
145
0.270
 Why?
Etoposide
1
2008
165
0.270
 Why?
Carcinoembryonic Antigen
2
2024
38
0.260
 Why?
Pathology, Molecular
2
2017
26
0.250
 Why?
Pathology, Clinical
2
2017
29
0.250
 Why?
Cancer Survivors
2
2024
301
0.250
 Why?
Shock, Septic
1
2009
220
0.250
 Why?
Health Services Accessibility
1
2015
1084
0.250
 Why?
Drug Administration Schedule
4
2019
777
0.240
 Why?
Organ Sparing Treatments
1
2026
38
0.240
 Why?
B7-H1 Antigen
3
2026
243
0.240
 Why?
ras Proteins
2
2017
149
0.230
 Why?
Anus Neoplasms
1
2026
33
0.230
 Why?
Ipilimumab
1
2026
41
0.230
 Why?
CD47 Antigen
1
2025
43
0.230
 Why?
Age Factors
5
2021
3336
0.220
 Why?
Diagnosis, Differential
1
2009
1515
0.220
 Why?
Oximes
1
2024
26
0.210
 Why?
Fluorescence Resonance Energy Transfer
1
2025
177
0.210
 Why?
Young Adult
6
2026
14021
0.210
 Why?
Prognosis
10
2026
4207
0.210
 Why?
CD3 Complex
1
2024
110
0.210
 Why?
Cell Line, Tumor
6
2025
3626
0.200
 Why?
United States
13
2025
15694
0.200
 Why?
Deoxycytidine
3
2024
203
0.200
 Why?
Metastasectomy
1
2023
22
0.200
 Why?
Extracellular Vesicles
1
2025
163
0.200
 Why?
Antibodies, Bispecific
1
2024
65
0.200
 Why?
Trifluridine
1
2022
3
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2022
76
0.190
 Why?
Retrospective Studies
11
2026
16942
0.190
 Why?
Signal Transduction
6
2018
5242
0.190
 Why?
Surgical Oncology
1
2022
30
0.190
 Why?
Neoplasm Grading
2
2024
313
0.190
 Why?
Clinical Trials, Phase III as Topic
2
2022
115
0.180
 Why?
Empathy
1
2024
181
0.180
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2023
166
0.180
 Why?
Genetic Testing
3
2022
475
0.180
 Why?
Databases, Factual
4
2017
1478
0.180
 Why?
Ovarian Neoplasms
2
2020
591
0.180
 Why?
Disease Models, Animal
4
2021
4553
0.180
 Why?
Survival Rate
6
2023
2025
0.180
 Why?
Chemoradiotherapy, Adjuvant
2
2023
44
0.180
 Why?
Membrane Proteins
3
2019
1179
0.180
 Why?
Incidence
6
2022
2864
0.170
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
39
0.170
 Why?
Neoplasms, Multiple Primary
1
2022
59
0.170
 Why?
Gene Regulatory Networks
1
2024
323
0.170
 Why?
Tumor Microenvironment
2
2023
737
0.170
 Why?
DNA
1
2008
1458
0.170
 Why?
Pheochromocytoma
1
2022
58
0.170
 Why?
Meningioma
1
2022
89
0.170
 Why?
Capecitabine
2
2022
42
0.170
 Why?
Congresses as Topic
2
2019
227
0.160
 Why?
Heterografts
1
2021
138
0.160
 Why?
Health Status Disparities
2
2020
316
0.160
 Why?
Artificial Intelligence
1
2024
366
0.160
 Why?
Practice Patterns, Physicians'
1
2009
1372
0.150
 Why?
Immune System
1
2021
183
0.150
 Why?
Adenomatous Polyposis Coli Protein
1
2019
21
0.150
 Why?
Smad4 Protein
1
2019
36
0.150
 Why?
Area Under Curve
2
2018
328
0.150
 Why?
Retinal Vein
1
2019
13
0.150
 Why?
GTP Phosphohydrolases
1
2019
96
0.150
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
101
0.140
 Why?
Tumor Suppressor Protein p53
2
2022
544
0.140
 Why?
Prevalence
2
2026
2849
0.140
 Why?
Cell-Free Nucleic Acids
1
2019
33
0.140
 Why?
Animals
12
2025
38224
0.140
 Why?
Vasculitis
1
2019
68
0.140
 Why?
Genes, ras
1
2018
94
0.140
 Why?
Disease Progression
4
2017
2889
0.140
 Why?
Neoplasm Transplantation
1
2018
253
0.140
 Why?
Retinal Diseases
1
2019
96
0.140
 Why?
Evidence-Based Medicine
2
2019
727
0.130
 Why?
Proportional Hazards Models
3
2017
1296
0.130
 Why?
Drug Combinations
2
2022
386
0.130
 Why?
Survivorship
1
2018
53
0.130
 Why?
Cohort Studies
6
2020
5895
0.130
 Why?
Acneiform Eruptions
1
2017
1
0.130
 Why?
Patient Advocacy
1
2018
76
0.130
 Why?
Asthenia
1
2017
3
0.130
 Why?
Risk Assessment
2
2019
3595
0.130
 Why?
Population Surveillance
1
2021
493
0.130
 Why?
Risk Factors
6
2022
10739
0.130
 Why?
Drug Eruptions
1
2017
30
0.130
 Why?
Hypokalemia
1
2017
24
0.130
 Why?
Histone Deacetylase Inhibitors
1
2019
219
0.130
 Why?
Receptor, ErbB-3
1
2017
46
0.130
 Why?
MAP Kinase Kinase 1
1
2017
75
0.130
 Why?
Intercellular Signaling Peptides and Proteins
2
2015
388
0.130
 Why?
Patient Compliance
1
2021
618
0.130
 Why?
Esophageal Neoplasms
1
2021
345
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
262
0.130
 Why?
Consensus
1
2019
494
0.130
 Why?
Neoplasm Recurrence, Local
2
2023
1109
0.120
 Why?
Digestive System Neoplasms
1
2016
9
0.120
 Why?
Antineoplastic Agents, Immunological
1
2019
196
0.120
 Why?
Liver Neoplasms
2
2024
768
0.120
 Why?
Hospitals
1
2021
692
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
318
0.120
 Why?
Edema
1
2016
127
0.120
 Why?
Time Factors
2
2019
7074
0.120
 Why?
Triple Negative Breast Neoplasms
1
2019
206
0.120
 Why?
Adolescent
5
2026
22670
0.120
 Why?
Biomarkers
3
2023
4276
0.120
 Why?
Diabetic Neuropathies
1
2016
97
0.120
 Why?
Biliary Tract Neoplasms
1
2015
30
0.120
 Why?
GPI-Linked Proteins
1
2016
80
0.120
 Why?
Device Approval
1
2015
17
0.110
 Why?
Receptor, Notch1
1
2015
65
0.110
 Why?
Immunoblotting
1
2015
313
0.110
 Why?
Mice
7
2025
18497
0.110
 Why?
Patient Care Planning
1
2016
167
0.110
 Why?
Neuralgia
1
2016
142
0.110
 Why?
Delivery of Health Care, Integrated
1
2018
295
0.110
 Why?
Gene Dosage
1
2015
147
0.110
 Why?
Health Behavior
1
2020
793
0.110
 Why?
Pancreas
1
2017
335
0.110
 Why?
Analgesics
1
2016
236
0.110
 Why?
Administration, Oral
1
2017
847
0.110
 Why?
Drug Approval
1
2015
88
0.110
 Why?
Gene Expression Regulation
1
2024
2621
0.110
 Why?
DNA Copy Number Variations
1
2015
184
0.110
 Why?
Quality of Life
2
2024
3100
0.110
 Why?
Immunoconjugates
1
2016
133
0.110
 Why?
Quinazolines
1
2015
261
0.100
 Why?
Genetic Variation
1
2019
1012
0.100
 Why?
United States Food and Drug Administration
1
2015
201
0.100
 Why?
Phenotype
2
2021
3236
0.100
 Why?
Proto-Oncogene Proteins
1
2017
627
0.100
 Why?
Delivery of Health Care
1
2021
954
0.100
 Why?
Liquid Biopsy
2
2025
13
0.100
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
763
0.100
 Why?
Lung Neoplasms
2
2024
2603
0.100
 Why?
beta Catenin
1
2015
256
0.100
 Why?
Patient-Centered Care
1
2018
551
0.100
 Why?
National Cancer Institute (U.S.)
2
2025
48
0.100
 Why?
Spinal Cord Injuries
1
2016
238
0.100
 Why?
Randomized Controlled Trials as Topic
1
2019
1673
0.090
 Why?
Lymphocytes
1
2015
400
0.090
 Why?
Registries
1
2021
2254
0.090
 Why?
Risk
1
2014
907
0.090
 Why?
Angiogenesis Inhibitors
1
2013
239
0.090
 Why?
Protein Kinase Inhibitors
1
2018
983
0.090
 Why?
Ligands
1
2013
672
0.090
 Why?
Neoplasm, Residual
2
2022
134
0.080
 Why?
Prospective Studies
3
2022
7956
0.080
 Why?
Patient Care Team
1
2016
687
0.080
 Why?
Protein-Tyrosine Kinases
1
2013
432
0.080
 Why?
Activities of Daily Living
1
2014
433
0.080
 Why?
Apoptosis
3
2022
2514
0.080
 Why?
Mice, Nude
2
2024
709
0.080
 Why?
Streptococcaceae
1
2009
2
0.080
 Why?
Cytokines
2
2015
2102
0.070
 Why?
Clinical Medicine
1
2009
25
0.070
 Why?
Patient Satisfaction
1
2013
702
0.070
 Why?
Neutrophils
1
2015
1143
0.070
 Why?
Transcriptome
1
2015
1043
0.070
 Why?
Chemoradiotherapy
2
2023
234
0.070
 Why?
Myositis
1
2009
58
0.070
 Why?
Sulindac
1
2008
16
0.070
 Why?
Bortezomib
1
2008
52
0.070
 Why?
Mutation Rate
2
2019
30
0.070
 Why?
Taiwan
1
2008
46
0.070
 Why?
Combined Modality Therapy
1
2011
1263
0.070
 Why?
Nausea
1
2008
112
0.070
 Why?
Immunoenzyme Techniques
1
2008
206
0.070
 Why?
Neutropenia
1
2008
152
0.070
 Why?
Multivariate Analysis
3
2017
1514
0.070
 Why?
Fluphenazine
1
2007
5
0.070
 Why?
Risperidone
1
2007
30
0.060
 Why?
Nerve Fibers, Myelinated
1
2007
47
0.060
 Why?
Drug Therapy, Combination
1
2010
1064
0.060
 Why?
Food
1
2008
161
0.060
 Why?
Anemia
1
2008
178
0.060
 Why?
Exons
1
2008
360
0.060
 Why?
Fasting
1
2008
285
0.060
 Why?
Thrombocytopenia
1
2008
211
0.060
 Why?
Frontal Lobe
1
2007
161
0.060
 Why?
Gastrectomy
2
2017
150
0.060
 Why?
Propensity Score
2
2017
356
0.060
 Why?
Antipsychotic Agents
1
2007
210
0.060
 Why?
Polymerase Chain Reaction
1
2008
1063
0.050
 Why?
Stroke
1
2014
1223
0.050
 Why?
Postoperative Complications
1
2017
2938
0.050
 Why?
Follow-Up Studies
2
2026
5345
0.050
 Why?
Survival Analysis
2
2017
1333
0.050
 Why?
Loneliness
1
2024
59
0.050
 Why?
Fluorescent Dyes
1
2025
325
0.050
 Why?
Delayed Diagnosis
1
2024
92
0.050
 Why?
Natural Language Processing
1
2024
104
0.050
 Why?
Oxidative Stress
1
2010
1376
0.050
 Why?
Paclitaxel
1
2024
237
0.050
 Why?
Thymine
1
2022
16
0.050
 Why?
Cyclooxygenase 2 Inhibitors
1
2022
24
0.050
 Why?
G2 Phase Cell Cycle Checkpoints
1
2022
45
0.050
 Why?
Equivalence Trials as Topic
1
2022
33
0.050
 Why?
Recombinant Fusion Proteins
1
2025
681
0.050
 Why?
Mice, Inbred BALB C
1
2025
1273
0.050
 Why?
Endothelial Growth Factors
1
2022
64
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
73
0.050
 Why?
Resilience, Psychological
1
2024
137
0.050
 Why?
Gallium Radioisotopes
1
2022
15
0.050
 Why?
Radioisotopes
1
2022
33
0.050
 Why?
Receptors, Peptide
1
2022
19
0.050
 Why?
Organoids
1
2024
133
0.050
 Why?
Radionuclide Imaging
1
2022
117
0.050
 Why?
Intestinal Neoplasms
1
2022
31
0.050
 Why?
Inflammasomes
1
2023
146
0.050
 Why?
Pyrrolidines
1
2022
123
0.040
 Why?
Neoplastic Syndromes, Hereditary
1
2021
43
0.040
 Why?
Quinolines
1
2022
178
0.040
 Why?
Radiopharmaceuticals
1
2022
191
0.040
 Why?
North America
1
2022
312
0.040
 Why?
Europe
1
2022
414
0.040
 Why?
Immune Tolerance
1
2023
381
0.040
 Why?
Chimerism
1
2021
34
0.040
 Why?
Positron Emission Tomography Computed Tomography
1
2022
119
0.040
 Why?
Preventive Medicine
1
2021
40
0.040
 Why?
Lymphocyte Subsets
1
2021
87
0.040
 Why?
Canada
1
2022
432
0.040
 Why?
Surveys and Questionnaires
2
2024
6062
0.040
 Why?
Lymphoid Tissue
1
2021
81
0.040
 Why?
Hyaluronic Acid
1
2022
229
0.040
 Why?
Positron-Emission Tomography
1
2022
313
0.040
 Why?
Mice, SCID
1
2021
374
0.040
 Why?
Geography
1
2020
202
0.040
 Why?
Morbidity
1
2021
321
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
227
0.040
 Why?
SEER Program
1
2020
221
0.040
 Why?
Mice, Inbred C57BL
2
2023
6054
0.040
 Why?
Mice, Inbred NOD
1
2021
611
0.040
 Why?
Spectrophotometry, Infrared
1
2019
54
0.040
 Why?
District of Columbia
1
2018
34
0.040
 Why?
Sulfonamides
1
2022
574
0.040
 Why?
Karnofsky Performance Status
1
2018
37
0.040
 Why?
Pyridines
1
2022
604
0.030
 Why?
Structure-Activity Relationship
1
2019
577
0.030
 Why?
Multimodal Imaging
1
2019
121
0.030
 Why?
Fluorescein Angiography
1
2019
185
0.030
 Why?
Colon
1
2020
307
0.030
 Why?
Melanoma
1
2024
811
0.030
 Why?
Half-Life
1
2017
148
0.030
 Why?
American Medical Association
1
2017
18
0.030
 Why?
RNA
1
2024
939
0.030
 Why?
Genome, Human
1
2019
429
0.030
 Why?
Gene Expression Profiling
1
2024
1801
0.030
 Why?
Lymphocytes, Tumor-Infiltrating
1
2019
220
0.030
 Why?
Reproducibility of Results
1
2024
3403
0.030
 Why?
Tomography, Optical Coherence
1
2019
268
0.030
 Why?
Needles
1
2016
63
0.030
 Why?
Radiotherapy, Adjuvant
1
2017
217
0.030
 Why?
Delphi Technique
1
2018
328
0.030
 Why?
Infusions, Intravenous
1
2017
423
0.030
 Why?
Genomic Instability
1
2017
63
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2017
138
0.030
 Why?
Cell Proliferation
1
2024
2551
0.030
 Why?
Health Services Needs and Demand
1
2018
283
0.030
 Why?
Molecular Diagnostic Techniques
1
2017
104
0.030
 Why?
Meta-Analysis as Topic
1
2017
169
0.030
 Why?
Retreatment
1
2016
75
0.030
 Why?
Algorithms
1
2024
1825
0.030
 Why?
Incidental Findings
1
2016
81
0.030
 Why?
DNA Mutational Analysis
1
2017
404
0.030
 Why?
Acute Disease
1
2019
1018
0.030
 Why?
Platinum
1
2016
51
0.030
 Why?
Gene Frequency
1
2017
492
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
23
0.030
 Why?
Radiography
2
2016
847
0.030
 Why?
Neoplasm Invasiveness
1
2017
523
0.030
 Why?
Gene Duplication
1
2015
67
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
685
0.030
 Why?
Endoscopy, Digestive System
1
2016
138
0.030
 Why?
Protein Isoforms
1
2016
404
0.030
 Why?
Practice Guidelines as Topic
1
2022
1566
0.030
 Why?
Preoperative Care
1
2017
383
0.030
 Why?
Magnetic Resonance Imaging
1
2007
3834
0.030
 Why?
Leukocyte Count
1
2015
317
0.030
 Why?
Analysis of Variance
1
2017
1315
0.030
 Why?
Calcium-Binding Proteins
1
2015
215
0.030
 Why?
Ultraviolet Rays
1
2016
401
0.030
 Why?
Mice, Knockout
1
2021
3126
0.030
 Why?
Societies, Medical
1
2018
878
0.030
 Why?
Behavior, Animal
1
2016
516
0.020
 Why?
Protein Processing, Post-Translational
1
2016
479
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2019
929
0.020
 Why?
Brain Neoplasms
1
2021
1310
0.020
 Why?
Logistic Models
1
2017
2111
0.020
 Why?
Skin
1
2016
774
0.020
 Why?
Immunohistochemistry
1
2016
1740
0.020
 Why?
Rats, Sprague-Dawley
1
2016
2531
0.020
 Why?
Cross-Sectional Studies
1
2022
5797
0.020
 Why?
Lung
1
2023
4131
0.020
 Why?
Angiogenesis Inducing Agents
1
2009
25
0.020
 Why?
Protein Binding
1
2016
2277
0.020
 Why?
Glycogen Synthase Kinase 3 beta
1
2008
74
0.020
 Why?
Rats
1
2016
5615
0.020
 Why?
Glycogen Synthase Kinase 3
1
2008
82
0.020
 Why?
Reference Standards
1
2008
181
0.020
 Why?
Pharmacogenetics
1
2008
169
0.020
 Why?
Infusions, Intra-Arterial
1
1986
62
0.020
 Why?
Hepatic Artery
1
1986
53
0.010
 Why?
Chromatography, High Pressure Liquid
1
2008
590
0.010
 Why?
Breast Neoplasms
1
2019
2340
0.010
 Why?
Predictive Value of Tests
1
2011
2098
0.010
 Why?
Reference Values
1
2007
814
0.010
 Why?
Tomography, X-Ray Computed
1
2016
2798
0.010
 Why?
Tandem Mass Spectrometry
1
2008
571
0.010
 Why?
Image Processing, Computer-Assisted
1
2007
774
0.010
 Why?
Longitudinal Studies
1
2007
3042
0.010
 Why?
Lieu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (411) concept(s)
_
Co-Authors Expand Description
See all (79) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)